Primovir 250 Nirmatrelvir Ritonavir Combipack Tablet

Name: Primovir 250 Nirmatrelvir Ritonavir Combipack Tablet
Brand: Shashvat Pharmaceuticals
Price: 7500 INR
Availability: InStock

Price 7500 INR/ Box

Get a Price/Quote

MOQ : 20 Boxes

Primovir 250 Nirmatrelvir Ritonavir Combipack Tablet Specification

Salt Composition
Nirmatrelvir & Ritonavir

Life Span
Check expiry on pack

Brand Name
Primovir

Pacakaging (Quantity Per Box)
3x10 Tablet

Indication
Treatment of mild to moderate COVID-19

Dosage Form
Tablet

Packaging Type
Box

Origin of Medicine
India

Drug Type
Prescription

Ingredients
Nirmatrelvir 150 mg, Ritonavir 100 mg

Physical Form
Film coated tablet

Function
Antiviral therapy for COVID-19

Recommended For
Adults as prescribed

Dosage
As directed by physician

Dosage Guidelines
Follow 5-day course

Suitable For
Adults

Quantity
30 tablets

Storage Instructions
Store below 30C, dry place

Strength
150 mg + 100 mg

Regimen
5 day course

Pack Size
30 tablets

Film Type
Coated

Course Duration
Short term use

Administration Route
Oral

Prescription Required
Yes

Tablet Color
Light yellow

Pack Type
Box

Primovir 250 Nirmatrelvir Ritonavir Combipack Tablet Trade Information

Minimum Order Quantity
20 Boxes

Payment Terms
Cash in Advance (CID)

Supply Ability
100 Boxes Per Month

Delivery Time
10 Days

Main Domestic Market
All India

About Primovir 250 Nirmatrelvir Ritonavir Combipack Tablet

Take advantage of this limited time offer and secure Primovir 250 Nirmatrelvir Ritonavir Combipack Tablet (150 mg + 100 mg) at a reduced price. Boasting a pristine film coating, this remarked antiviral solution offers impeccable efficacy as part of a 5-day course for COVID-19 treatment. Each light yellow tablet is expertly formulated for adult use under physician guidance. Supplied in a convenient 30-tablet box, Primovir is engineered in India and comes with stringent quality assurance-perfect for those seeking trusted, short-term COVID-19 therapy. Prescription required.

Primovir 250: Special Features and Competitive Edge

Primovir 250 Nirmatrelvir Ritonavir Combipack Tablet is designed for adults requiring short-term, prescription-based antiviral therapy. Its impeccable salt composition and pristine film-coated finish deliver optimum efficacy and patient comfort. Used by healthcare professionals across India, it stands out for precise dosage, convenient packaging, and trusted supply chain. Competitive advantages include a remarked record in clinical support, strict quality standards, and ease of oral administration, making it the preferred choice for mild to moderate COVID-19 cases.

Delivery, Market Reach, and Certification Highlights

Experience seamless transportation and quick dispatch of Primovir 250 across major domestic markets in India. Orders are shipped promptly from certified suppliers, ensuring that your medication arrives on time. Each box is handled with utmost care, reflecting top-tier pharmaceutical certifications and rigorous quality controls. The process integrates efficient logistics for rapid availability, allowing healthcare providers and patients to benefit from reliable, on-time delivery wherever required.

FAQ's of Primovir 250 Nirmatrelvir Ritonavir Combipack Tablet:

Q: How should Primovir 250 be administered for COVID-19 treatment?

A: Primovir 250 should be taken orally as a film-coated tablet, in the dosage and schedule prescribed by your physician, typically over a 5-day course for adults.

Q: What are the benefits of choosing Primovir 250 for COVID-19 therapy?

A: Primovir 250 offers impeccable efficacy for mild to moderate COVID-19, with a pristine formulation and reduced course duration, making it a trusted option for quick recovery.

Q: When is Primovir 250 recommended for use?

A: It is indicated for the treatment of mild to moderate COVID-19 symptoms in adults, as directed by a healthcare professional, and is intended for short-term use only.

Q: Where is Primovir 250 manufactured and supplied from?

A: Primovir 250 is manufactured in India and distributed by certified suppliers and traders throughout the country, ensuring reliable access and quality compliance.